Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population

Journal of the American College of Cardiology

Volumn 63, Issue 5, 2014, Pages 470-477

  Kamstrup, Pia R ^a   Tybjærg Hansen, Anne ^a,b,c,d   Nordestgaard, Børge G ^a,c,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

aortic valve stenosis; genes; Lp(a)

Indexed keywords

APOLIPOPROTEIN B; LIPOPROTEIN A;

ADULT; AORTA VALVE STENOSIS; ARTICLE; DANISH; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; FOLLOW UP; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; DNA STRUCTURE; GENETIC ASSOCIATION; HETEROZYGOTE; LPA GENE; OBSERVATIONAL STUDY;

AORTIC VALVE STENOSIS; AVS; CI; CONFIDENCE INTERVAL; GENES; ICD; INTERNATIONAL CLASSIFICATION OF DISEASES; KIV-2; KRINGLE IV TYPE 2; LP(A); SINGLE NUCLEOTIDE POLYMORPHISM; SNP;

AGED; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; DENMARK; FEMALE; HUMANS; HYPERLIPOPROTEINEMIAS; INCIDENCE; LIPOPROTEIN(A); MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84893333521     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.09.038     Document Type: Article

References (28)

1. P.R. Kamstrup, A. Tybjærg-Hansen, R. Steffensen, and B.G. Nordestgaard Genetically elevated lipoprotein(a) and increased risk of myocardial infarction JAMA 301 2009 2331 2339
2. R. Clarke, J.F. Peden, and J.C. Hopewell et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease N Engl J Med 361 2009 2518 2528
3. P.R. Kamstrup Lipoprotein(a) and ischemic heart disease - a causal association? A review Atherosclerosis 211 2010 15 23
4. B.G. Nordestgaard, M.J. Chapman, and K. Ray et al. Lipoprotein(a) as a cardiovascular risk factor: current status Eur Heart J 31 2010 2844 2853
5. G. Thanassoulis, C.Y. Campbell, and D.S. Owens et al. Genetic associations with valvular calcification and aortic stenosis N Engl J Med 368 2013 503 512
6. B. Iung, and A. Vahanian Epidemiology of valvular heart disease in the adult Nat Rev Cardiol 8 2011 162 172
7. A. Vahanian, O. Alfieri, and F. Andreotti et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 33 2012 2451 2496
8. C. Li, S. Xu, and A.I. Gotlieb The response to valve injury. A paradigm to understand the pathogenesis of heart valve disease Cardiovasc Pathol 20 2011 183 190
9. N.M. Rajamannan, F.J. Evans, and E. Aikawa et al. Calcific aortic valve disease: not simply a degenerative process. A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease - 2011 update Circulation 124 2011 1783 1791
10. B.F. Stewart, D. Siscovick, and B.K. Lind et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study J Am Coll Cardiol 29 1997 630 634
11. W.C. Roberts, and J.M. Ko Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation Circulation 111 2005 920 925
12. G. Utermann Lipoprotein(a) C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, The Metabolic and Molecular Bases of Inherited Disease 2006 McGraw-Hill, Medical Publishing Division New York, NY 2753 2787
13. A. Helgadottir, S. Gretarsdottir, and G. Thorleifsson et al. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism J Am Coll Cardiol 60 2012 722 729
14. P.R. Kamstrup, A. Tybjærg-Hansen, and B.G. Nordestgaard Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis Arterioscler Thromb Vasc Biol 32 2012 1732 1741
15. M.S. Brown, and J.L. Goldstein Plasma lipoproteins: teaching old dogmas new tricks Nature 330 1987 113 114
16. Y. Yano, K. Shimokawa, Y. Okada, and A. Noma Immunolocalization of lipoprotein(a) in wounded tissues J Histochem Cytochem 45 1997 559 568
17. D.A. Lawlor, R.M. Harbord, J.A. Sterne, N. Timpson, and S.G. Davey Mendelian randomization: using genes as instruments for making causal inferences in epidemiology Stat Med 27 2008 1133 1163
18. P. Schnohr, G. Jensen, P. Lange, H. Scharling, and M. Appleyard The Copenhagen City Heart Study. ∅sterbroundersøgelsen. Tables with data from the third examination, 1991-1994 Eur Heart J 3 2001 H1 H83
19. R. Clarke, M. Shipley, and S. Lewington et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 1999 341 353
20. B.G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjærg-Hansen Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 2007 299 308
21. P.R. Kamstrup, M. Benn, A. Tybjærg-Hansen, and B.G. Nordestgaard Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study Circulation 117 2008 176 184
22. S. Erqou, S. Kaptoge, and P.L. Perry et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
23. L.B. Nielsen, S. Stender, K. Kjeldsen, and B.G. Nordestgaard Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo Circ Res 78 1996 615 626
24. K.D. O'Brien, D.D. Reichenbach, S.M. Marcovina, J. Kuusisto, C.E. Alpers, and C.M. Otto Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of "degenerative" valvular aortic stenosis Arterioscler Thromb Vasc Biol 16 1996 523 532
25. H. Bozbas, A. Yildirir, and I. Atar et al. Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification J Heart Valve Dis 16 2007 387 393
26. C.A. Glader, L.S. Birgander, and S. Soderberg et al. Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis Eur Heart J 24 2003 198 208
27. T. Gotoh, T. Kuroda, and M. Yamasawa et al. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study) Am J Cardiol 76 1995 928 932
28. R. Erbel, N. Lehmann, and S. Churzidse et al. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study Atherosclerosis 229 2013 531 540